Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ev3 takes thrombectomy catheter to the US:

This article was originally published in Clinica

Executive Summary

ev3 has received US market approval to use its thrombus-clearing device in synthetic vessel grafts in haemodialysis patients. The X-Sizer thrombectomy catheter uses a helical cutter and vacuum to shear and remove blood thrombus from the graft without trauma, says the Plymouth, Minnesota firm. The cutter is operated by a battery-powered control unit. As a fully contained device, the system eliminates the need for large control consoles or power supplies common with other mechanical thrombus removal systems, the company claims. The device has been available for removing blood clot in coronary arteries and saphenous vein grafts for several years in Europe and other parts of the world.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel